Shire Stock Price, News & Analysis (LON:SHP)

GBX 3,511 50.00 (1.44 %)
(As of 01/22/2018 04:00 PM ET)
Previous CloseGBX 3,511
Today's RangeGBX 3,470 - GBX 3,577.50
52-Week RangeGBX 3,403.50 - GBX 5,067
Volume1.75 million shs
Average Volume2.52 million shs
Market Capitalization£32.04 billion
P/E Ratio2,742.97
Dividend YieldN/A
BetaN/A

About Shire (LON:SHP)

Shire logoShire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

Receive SHP News and Ratings via Email

Sign-up to receive the latest news and ratings for SHP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolLON:SHP
CUSIPN/A
Phone+353-1-6096000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio2742.96875
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX 1.28
Net IncomeN/A
Net Margins15.00%
Return on Equity6.92%
Return on Assets3.30%

Miscellaneous

EmployeesN/A
Outstanding Shares908,640,000

Shire (LON:SHP) Frequently Asked Questions

What is Shire's stock symbol?

Shire trades on the London Stock Exchange (LON) under the ticker symbol "SHP."

How often does Shire pay dividends? What is the dividend yield for Shire?

Shire declared a dividend on Thursday, August 3rd. Investors of record on Thursday, September 7th will be paid a dividend of GBX 3.85 per share on Friday, October 20th. This represents a yield of 0.1%. The ex-dividend date is Thursday, September 7th. The official announcement can be viewed at this link. View Shire's Dividend History.

Where is Shire's stock going? Where will Shire's stock price be in 2018?

16 brokerages have issued 1 year target prices for Shire's stock. Their predictions range from GBX 3,800 to GBX 8,000. On average, they anticipate Shire's share price to reach GBX 5,156.67 in the next year. View Analyst Ratings for Shire.

Who are some of Shire's key competitors?

Who are Shire's key executives?

Shire's management team includes the folowing people:

  • Flemming Ornskov M.D., Chief Executive Officer, Executive Director (Age 59)
  • John Miller, Interim Chief Financial Officer
  • Joanne Cordeiro, Chief Human Resource Officer
  • Andreas Busch Ph.D., Executive Vice President - Head of Research and Development, Chief Scientific Officer (Age 54)
  • Gisele Dion, Chief Accounting Officer, Corporate Controller (Age 51)
  • William Mordan, General Counsel, Company Secretary (Age 47)
  • Howard Mayer M.D., Chief Medical Officer
  • Perry Sternberg, Head - U.S. Commercial (Age 48)
  • Kim Stratton, Head - International Commercial (Age 54)
  • Philip J. Vickers, Head - Research and Development (Age 56)

How do I buy Shire stock?

Shares of Shire and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Shire's stock price today?

One share of Shire stock can currently be purchased for approximately GBX 3,511.

How big of a company is Shire?

Shire has a market capitalization of £32.04 billion.

How can I contact Shire?

Shire's mailing address is Miesian Plaza 50-58 Baggot Street Lower, Block 2, DUBLIN, D02 HW68, Ireland. The biopharmaceutical company can be reached via phone at +353-1-6096000.


MarketBeat Community Rating for Shire (SHP)

Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  1,155 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  1,412
MarketBeat's community ratings are surveys of what our community members think about Shire and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Shire (LON:SHP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.882.882.943.00
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: GBX 5,156.67GBX 5,365.63GBX 5,949GBX 6,209.57

Shire (LON:SHP) Consensus Price Target History

Price Target History for Shire (LON:SHP)

Shire (LON:SHP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
1/22/2018BarclaysReiterated RatingEqual weightView Rating Details
1/16/2018BNP ParibasReiterated RatingOutperformGBX 4,700View Rating Details
1/15/2018Shore CapitalReiterated RatingBuyView Rating Details
1/15/2018Liberum CapitalReiterated RatingHoldGBX 4,100View Rating Details
1/11/2018Deutsche BankReiterated RatingBuyGBX 5,000View Rating Details
1/10/2018JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
1/5/2018CitigroupReiterated RatingBuyGBX 5,500View Rating Details
12/1/2017Morgan StanleyReiterated RatingOverweightGBX 5,700View Rating Details
11/29/2017Societe GeneraleBoost Price TargetBuyGBX 7,500 -> GBX 8,000View Rating Details
11/24/2017Goldman Sachs GroupReiterated RatingConviction-BuyGBX 6,000View Rating Details
11/21/2017HSBCLower Price TargetHoldGBX 4,050 -> GBX 3,800View Rating Details
11/17/2017Kepler Capital MarketsReiterated RatingBuyGBX 4,600View Rating Details
11/17/2017Royal Bank of CanadaReiterated RatingOutperformView Rating Details
11/6/2017Berenberg BankBoost Price TargetBuyGBX 5,900 -> GBX 6,000View Rating Details
10/30/2017Credit Suisse GroupReiterated RatingOutperformGBX 4,500View Rating Details
8/22/2017Jefferies GroupReiterated RatingBuyView Rating Details
8/4/2017Beaufort SecuritiesReiterated RatingLong Term BuyGBX 6,200 -> GBX 4,900View Rating Details
1/9/2017Bryan, Garnier & CoReiterated RatingBuyGBX 6,800View Rating Details
11/7/2016AlphaValueReiterated RatingBuyGBX 6,714View Rating Details
11/3/2016Bank of AmericaReiterated RatingBuyGBX 6,970View Rating Details
3/15/2016Sanford C. BernsteinReiterated RatingOutperformGBX 5,000View Rating Details
(Data available from 1/22/2016 forward)

Earnings

Earnings History for Shire (LON:SHP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Shire (LON:SHP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Shire (LON:SHP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/3/2017GBX 3.850.1%9/7/20179/7/201710/20/2017
2/16/2017GBX 20.640.43%3/9/20173/9/20174/25/2017
8/2/2016GBX 3.510.07%9/8/20169/8/201610/7/2016
2/11/2016GBX 15.320.44%3/10/20163/10/20164/12/2016
7/23/2015GBX 2.690.05%9/3/20159/3/201510/2/2015
7/18/2014GBX 2.240.04%9/3/20149/3/201410/3/2014
2/13/2014GBX 10.210.31%3/5/20143/5/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Shire (LON SHP) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Shire (LON:SHP)

Shire (LON SHP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2017Dominic BlakemoreInsiderBuy165GBX 3,790£6,253.50
9/29/2017Anne MintoInsiderBuy190GBX 3,785£7,191.50
8/22/2017Flemming OrnskovInsiderBuy8,400GBX 3,665£307,860
6/30/2017Dominic BlakemoreInsiderBuy152GBX 4,255£6,467.60
3/31/2017William BurnsInsiderBuy136GBX 4,742£6,449.12
12/16/2016Olivier BohuonInsiderBuy141GBX 4,528£6,384.48
9/30/2016Dominic BlakemoreInsiderBuy133GBX 5,010£6,663.30
6/30/2016Bohuon,OlivierInsiderBuy134GBX 4,463£5,980.42
3/31/2016Bohuon,OlivierInsiderBuy133GBX 3,908£5,197.64
2/15/2016Bohuon,OlivierInsiderBuy1,000GBX 3,552£35,520
2/12/2016Burns,WilliamInsiderBuy1,250GBX 3,563£44,537.50
12/18/2015Burns,WilliamInsiderBuy156GBX 4,457£6,952.92
9/30/2015Blakemore ,DominicInsiderBuy129GBX 4,498£5,802.42
6/30/2015Kappler,David JInsiderBuy126GBX 51.05GBX 6,432.30
3/31/2015Susan KilsbyInsiderBuy375GBX 5,327£19,976.25
12/19/2014Steven GillisInsiderBuy228GBX 4,654£10,611.12
10/30/2014Steven GillisInsiderBuy381GBX 4,098£15,613.38
(Data available from 1/1/2013 forward)

Headlines

Shire (LON SHP) News Headlines

Source:
DateHeadline
Shire PLC (SHP) Receives Consensus Recommendation of "Buy" from BrokeragesShire PLC (SHP) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 16 at 9:56 AM
Shire (SHP) Given Buy Rating at Shore CapitalShire (SHP) Given Buy Rating at Shore Capital
www.americanbankingnews.com - January 16 at 12:40 AM
Shire (SHP) Given Buy Rating at Deutsche BankShire (SHP) Given Buy Rating at Deutsche Bank
www.americanbankingnews.com - January 11 at 6:46 AM
Shire To Operate As Two Divisions: Rare Disease And Neuroscience - NasdaqShire To Operate As Two Divisions: Rare Disease And Neuroscience - Nasdaq
www.nasdaq.com - January 9 at 4:40 PM
Shire announces reorganization, sets sales targetShire announces reorganization, sets sales target
www.marketwatch.com - January 8 at 4:43 PM
Citigroup Reiterates Buy Rating for Shire (SHP)Citigroup Reiterates Buy Rating for Shire (SHP)
www.americanbankingnews.com - January 7 at 1:28 PM
Shire to present at the 36th Annual JP Morgan Healthcare Conference - GlobeNewswire (press release)Shire to present at the 36th Annual JP Morgan Healthcare Conference - GlobeNewswire (press release)
www.globenewswire.com - January 4 at 10:13 AM
Shire plc : Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for ... - GlobeNewswire (press release)Shire plc : Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for ... - GlobeNewswire (press release)
globenewswire.com - January 4 at 10:13 AM
Shires dry eye treatment approved in CanadaShire's dry eye treatment approved in Canada
www.marketwatch.com - January 3 at 9:34 AM
Shire (SHP) Given "Buy" Rating at Shore CapitalShire (SHP) Given "Buy" Rating at Shore Capital
www.americanbankingnews.com - December 31 at 7:25 PM
Shire (SHP) Price Target Increased to GBX 8,000 by Analysts at Societe GeneraleShire (SHP) Price Target Increased to GBX 8,000 by Analysts at Societe Generale
www.americanbankingnews.com - December 31 at 9:46 AM
Healthcare: Pick Carefully as Valuations Head HigherHealthcare: Pick Carefully as Valuations Head Higher
finance.yahoo.com - December 28 at 8:52 AM
Shire Files For FDA Approval Of Plasma Manufacturing Facility In ... - NasdaqShire Files For FDA Approval Of Plasma Manufacturing Facility In ... - Nasdaq
www.nasdaq.com - December 27 at 1:06 PM
Shire: If You Build It…Shire: If You Build It…
finance.yahoo.com - December 27 at 1:06 PM
Will Shire plc’s (LON:SHP) Earnings Grow Over The Next Few Years?Will Shire plc’s (LON:SHP) Earnings Grow Over The Next Few Years?
finance.yahoo.com - December 25 at 6:09 PM
Shire (SHP) Earns Buy Rating from Deutsche BankShire (SHP) Earns Buy Rating from Deutsche Bank
www.americanbankingnews.com - December 25 at 10:46 AM
Shire (SHP) Rating Lowered to Hold at Liberum CapitalShire (SHP) Rating Lowered to Hold at Liberum Capital
www.americanbankingnews.com - December 23 at 10:00 PM
Shire PLC (SHP) Given Consensus Rating of "Buy" by AnalystsShire PLC (SHP) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - December 22 at 10:30 AM
Shire PLC (SHP) Insider Dominic Blakemore Buys 165 SharesShire PLC (SHP) Insider Dominic Blakemore Buys 165 Shares
www.americanbankingnews.com - December 20 at 8:24 AM
UPDATE: Shire SHP609 Trial Misses, myPKFiT Cleared By FDAUPDATE: Shire SHP609 Trial Misses, myPKFiT Cleared By FDA
www.morningstar.co.uk - December 19 at 4:35 PM
Shire plc : Novel Clinical Study Collaboration Announced Designed ... - GlobeNewswire (press release)Shire plc : Novel Clinical Study Collaboration Announced Designed ... - GlobeNewswire (press release)
globenewswire.com - December 14 at 5:07 PM
Shire: ONCASPAR Formulation Receives Marketing Authorization In EuropeShire: ONCASPAR Formulation Receives Marketing Authorization In Europe
www.rttnews.com - December 13 at 10:40 AM
Shire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : December 12, 2017Shire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : December 12, 2017
finance.yahoo.com - December 12 at 10:45 AM
Shire names John Miller interim CFOShire names John Miller interim CFO
www.marketwatch.com - December 9 at 10:18 AM
Shire (SHP) Given Buy Rating at CitigroupShire (SHP) Given Buy Rating at Citigroup
www.americanbankingnews.com - December 8 at 10:34 AM
Shire names new chief scientific, medical officersShire names new chief scientific, medical officers
www.marketwatch.com - December 1 at 5:36 PM
Shire (SHP) Receives Overweight Rating from Morgan StanleyShire (SHP) Receives Overweight Rating from Morgan Stanley
www.americanbankingnews.com - December 1 at 6:43 AM
Shire PLC (SHP) Given Average Recommendation of "Buy" by AnalystsShire PLC (SHP) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 27 at 1:34 PM
Shire PLC (SHP) Rating Reiterated by Liberum CapitalShire PLC (SHP) Rating Reiterated by Liberum Capital
www.americanbankingnews.com - November 26 at 12:08 AM
Liberum Capital Reaffirms Buy Rating for Shire PLC (SHP)Liberum Capital Reaffirms Buy Rating for Shire PLC (SHP)
www.americanbankingnews.com - November 24 at 7:28 PM
Deutsche Bank AG Reiterates Buy Rating for Shire PLC (SHP)Deutsche Bank AG Reiterates Buy Rating for Shire PLC (SHP)
www.americanbankingnews.com - November 24 at 6:04 PM
Shire Plc – Value Analysis (LONDON:SHP) : November 24, 2017Shire Plc – Value Analysis (LONDON:SHP) : November 24, 2017
finance.yahoo.com - November 24 at 6:03 PM
Shire PLC (SHP) Earns Conviction-Buy Rating from Goldman Sachs Group, Inc. (The)Shire PLC (SHP) Earns Conviction-Buy Rating from Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - November 24 at 10:56 AM
Shire PLCs (SHP) Overweight Rating Reaffirmed at J P Morgan Chase & CoShire PLC's (SHP) Overweight Rating Reaffirmed at J P Morgan Chase & Co
www.americanbankingnews.com - November 23 at 11:58 PM
Shire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : November 23, 2017Shire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : November 23, 2017
finance.yahoo.com - November 23 at 10:41 AM
HSBC Holdings PLC Lowers Shire PLC (SHP) Price Target to GBX 3,800HSBC Holdings PLC Lowers Shire PLC (SHP) Price Target to GBX 3,800
www.americanbankingnews.com - November 22 at 12:56 AM
Shire names Thomas Dittrich CFOShire names Thomas Dittrich CFO
www.marketwatch.com - November 20 at 9:54 AM
Why Shire plc (LSE:SHP) Could Be A BuyWhy Shire plc (LSE:SHP) Could Be A Buy
finance.yahoo.com - November 20 at 9:54 AM
Shire PLCs (SHP) "Outperform" Rating Reaffirmed at Royal Bank Of CanadaShire PLC's (SHP) "Outperform" Rating Reaffirmed at Royal Bank Of Canada
www.americanbankingnews.com - November 18 at 4:20 PM
Shire PLC (SHP) Rating Reiterated by Kepler Capital MarketsShire PLC (SHP) Rating Reiterated by Kepler Capital Markets
www.americanbankingnews.com - November 18 at 4:20 PM
CHMP recommends EU marketing authorization for...CHMP recommends EU marketing authorization for...
www.benzinga.com - November 14 at 7:53 AM
Shire presentations at ASH 2017 highlight commitment to furthering ... - NasdaqShire presentations at ASH 2017 highlight commitment to furthering ... - Nasdaq
www.nasdaq.com - November 11 at 1:34 PM
Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and ... - GlobeNewswire (press release)Shire presentations at ASH 2017 highlight commitment to furthering research and innovation in Hematology and ... - GlobeNewswire (press release)
globenewswire.com - November 10 at 11:56 AM
Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer - Business Wire (press release)Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer - Business Wire (press release)
www.businesswire.com - November 1 at 8:40 AM
Xenetic Biosciences Appoints Jeffrey F. Eisenberg As Chief Executive OfficerXenetic Biosciences Appoints Jeffrey F. Eisenberg As Chief Executive Officer
www.thestreet.com - October 31 at 9:26 AM
Edited Transcript of SHP.L earnings conference call or presentation 27-Oct-17 1:00pm GMTEdited Transcript of SHP.L earnings conference call or presentation 27-Oct-17 1:00pm GMT
finance.yahoo.com - October 31 at 9:26 AM
Shire PLC (SHP) Stock Rating Reaffirmed by Credit Suisse GroupShire PLC (SHP) Stock Rating Reaffirmed by Credit Suisse Group
www.americanbankingnews.com - October 30 at 9:22 AM
Shire PLC (SHP) Given "Equal weight" Rating at Barclays PLCShire PLC (SHP) Given "Equal weight" Rating at Barclays PLC
www.americanbankingnews.com - October 30 at 6:56 AM
Shire PLCs (SHP) "Buy" Rating Reaffirmed at Citigroup Inc.Shire PLC's (SHP) "Buy" Rating Reaffirmed at Citigroup Inc.
www.americanbankingnews.com - October 30 at 6:56 AM
Shire Q3 Adj. Profit Tops View, But Revenues Miss; Backs 2017 OutlookShire Q3 Adj. Profit Tops View, But Revenues Miss; Backs 2017 Outlook
www.rttnews.com - October 27 at 6:01 PM

SEC Filings

Shire (LON:SHP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Shire (LON SHP) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.